Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/97365Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sierra, Josep M. | - |
| dc.contributor.author | Camoez, Mariana | - |
| dc.contributor.author | Tubau, Fe | - |
| dc.contributor.author | Gasch, Oriol | - |
| dc.contributor.author | Pujol Rojo, Miquel | - |
| dc.contributor.author | Martín, Rogelio | - |
| dc.contributor.author | Domínguez Luzón, Ma. Ángeles (María Ángeles) | - |
| dc.date.accessioned | 2016-04-13T15:13:41Z | - |
| dc.date.available | 2016-04-13T15:13:41Z | - |
| dc.date.issued | 2013 | - |
| dc.identifier.issn | 1932-6203 | - |
| dc.identifier.uri | https://hdl.handle.net/2445/97365 | - |
| dc.description.abstract | Linezolid is an effective antimicrobial agent to treat methicillin-resistant Staphylococcus aureus (MRSA). Resistance to linezolid due to the cfr gene is described worldwide. The present study aimed to analyze the prevalence of the cfr-mediated linezolid resistance among MRSA clinical isolates in our area. A very low prevalence of cfr mediated linezolid resistance was found: only one bacteremic isolate out of 2 215 screened isolates. The only linezolid resistant isolate arose in a patient, previously colonized by MRSA, following linezolid therapy. Despite the low rate of resistance in our area, ongoing surveillance is advisable to avoid the spread of linezolid resistance. | - |
| dc.format.extent | 3 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | Public Library of Science (PLoS) | - |
| dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0059215 | - |
| dc.relation.ispartof | PLoS One, 2013, vol. 8, num. 3 | - |
| dc.relation.uri | http://dx.doi.org/10.1371/journal.pone.0059215 | - |
| dc.rights | cc-by (c) Sierra, J.M. et al., 2013 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
| dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
| dc.subject.classification | Staphylococcus aureus | - |
| dc.subject.classification | Unitats de cures intensives | - |
| dc.subject.classification | Infeccions respiratòries | - |
| dc.subject.other | Staphylococcus aureus | - |
| dc.subject.other | Intensive care units | - |
| dc.subject.other | Respiratory infections | - |
| dc.title | Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.identifier.idgrec | 638652 | - |
| dc.date.updated | 2016-04-13T15:13:46Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| dc.identifier.pmid | 23554998 | - |
| Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 638652.pdf | 123.44 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
